TIAA CREF Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-197,822
| Closed | -$673K | – | 3053 |
|
|
2018
Q3 | $673K | Sell |
197,822
-4,416
| -2% | -$15K | ﹤0.01% | 2600 |
|
|
2018
Q2 | $760K | Sell |
202,238
-2,505
| -1% | -$9.41K | ﹤0.01% | 2604 |
|
|
2018
Q1 | $837K | Hold |
204,743
| – | – | ﹤0.01% | 2520 |
|
|
2017
Q4 | $952K | Sell |
204,743
-27,581
| -12% | -$128K | ﹤0.01% | 2490 |
|
|
2017
Q3 | $1.65M | Buy |
232,324
+11,988
| +5% | +$85.1K | ﹤0.01% | 2268 |
|
|
2017
Q2 | $1.59M | Buy |
220,336
+7,576
| +4% | +$54.8K | ﹤0.01% | 2315 |
|
|
2017
Q1 | $1.31M | Sell |
212,760
-14,526
| -6% | -$89.5K | ﹤0.01% | 2380 |
|
|
2016
Q4 | $1.33M | Sell |
227,286
-10,862
| -5% | -$63.7K | ﹤0.01% | 2393 |
|
|
2016
Q3 | $1.27K | Sell |
238,148
-73,302
| -24% | -$389 | ﹤0.01% | 2416 |
|
|
2016
Q2 | $2.06M | Sell |
311,450
-12,645
| -4% | -$83.7K | ﹤0.01% | 2097 |
|
|
2016
Q1 | $1.51M | Sell |
324,095
-12,619
| -4% | -$58.9K | ﹤0.01% | 2237 |
|
|
2015
Q4 | $1.7M | Sell |
336,714
-11,384
| -3% | -$57.5K | ﹤0.01% | 2270 |
|
|
2015
Q3 | $1.23M | Sell |
348,098
-14,863
| -4% | -$52.3K | ﹤0.01% | 2445 |
|
|
2015
Q2 | $3.62M | Buy |
362,961
+21,810
| +6% | +$218K | ﹤0.01% | 1913 |
|
|
2015
Q1 | $4.34M | Buy |
341,151
+21,886
| +7% | +$279K | ﹤0.01% | 1738 |
|
|
2014
Q4 | $4.52M | Sell |
319,265
-20,649
| -6% | -$292K | ﹤0.01% | 1693 |
|
|
2014
Q3 | $4.67M | Sell |
339,914
-8,882
| -3% | -$122K | ﹤0.01% | 1661 |
|
|
2014
Q2 | $5.36M | Buy |
348,796
+8,706
| +3% | +$134K | ﹤0.01% | 1649 |
|
|
2014
Q1 | $5.8M | Buy |
340,090
+13,245
| +4% | +$226K | ﹤0.01% | 1512 |
|
|
2013
Q4 | $4.23M | Sell |
326,845
-1,265
| -0.4% | -$16.4K | ﹤0.01% | 1761 |
|
|
2013
Q3 | $3.31M | Sell |
328,110
-14,713
| -4% | -$149K | ﹤0.01% | 1883 |
|
|
2013
Q2 | $2.56M | Buy |
+342,823
| New | +$2.56M | ﹤0.01% | 2008 |
|